These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9044964)

  • 1. [Treatment of toxoplasmosis retinochoroiditis with atovaquone in an immunocompetent patient].
    Hudde T; Althaus C; Schimkat M; Sundmacher R
    Klin Monbl Augenheilkd; 1996 Oct; 209(4):232-6. PubMed ID: 9044964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of toxoplasmosis retinochoroiditis with atovaquone in an AIDS patient].
    Schimkat M; Althaus C; Armbrecht C; Jablonowski H; Sundmacher R
    Klin Monbl Augenheilkd; 1995 Mar; 206(3):173-7. PubMed ID: 7616727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.
    Pearson PA; Piracha AR; Sen HA; Jaffe GJ
    Ophthalmology; 1999 Jan; 106(1):148-53. PubMed ID: 9917796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient.
    Baatz H; Mirshahi A; Puchta J; Gümbel H; Hattenbach LO
    Ocul Immunol Inflamm; 2006 Jun; 14(3):185-7. PubMed ID: 16766403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.
    Gormley PD; Pavesio CE; Minnasian D; Lightman S
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1171-5. PubMed ID: 9620076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?
    Winterhalter S; Severing K; Stammen J; Maier AK; Godehardt E; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1187-92. PubMed ID: 20437247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in ocular toxoplasmosis.
    Wakefield D; Cunningham ET; Pavesio C; Garweg JG; Zierhut M
    Ocul Immunol Inflamm; 2011 Feb; 19(1):2-9. PubMed ID: 21250922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
    Lebech AM; Lebech M; Børme KK; Mathiesen LR
    Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
    Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
    J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxoplasmic central chorioretinitis].
    Macarie S; Hulpuş A; Rusu I
    Oftalmologia; 2010; 54(2):71-4. PubMed ID: 20827914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New trends in ocular toxoplasmosis--the review].
    Borkowski PK
    Przegl Epidemiol; 2001; 55(4):483-93. PubMed ID: 11921736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent secondary frosted branch angiitis after toxoplasmosis vasculitis.
    Oh J; Huh K; Kim SW
    Acta Ophthalmol Scand; 2005 Feb; 83(1):115-7. PubMed ID: 15715571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasmosis.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):129-41. PubMed ID: 16282146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].
    Psilas K; Petroutsos G; Aspiotis M
    J Fr Ophtalmol; 1990; 13(11-12):551-3. PubMed ID: 2081846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy.
    Rao V; Schneider E; Proia AD; Fekrat S
    JAMA Ophthalmol; 2014 Sep; 132(9):1150-2. PubMed ID: 24993473
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual toxoplasmic chorioretinitis in advanced age: a diagnostic problem.
    Mataftsi A; Fragkou A; Vezyri E; Topouzis F; Diza E; Dimitrakos SA
    Semin Ophthalmol; 2011 Jan; 26(1):4-6. PubMed ID: 21275597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clindamycin therapy of suspected toxoplasmosis retinochoroiditis].
    Mittelviefhaus H
    Klin Monbl Augenheilkd; 1992 Feb; 200(2):123-7. PubMed ID: 1533697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.